Generic Drugs Market Research Reports

Our range of reports on generics, biosimilars and biobetters will help you to gain an accurate view of the current and future generics landscape. They will help you gain insight as to how to discover techniques to counter patent expiry, manage drug life cycles, identify opportunities for market entry, and benchmark performance.

Filter
Title Search
1 - 25 of 178 Products Sort by Display
Biosimilars Market by Product (Monoclonal antibodies (infliximab, rituximab, trastuzumab), Insulin, Interferon, Etanercept, Glucagon, Calcitonin), Indication (Oncology, Chronic Disease, Blood Disorder, Autoimmune Disease), Region/Global Forecast -2026
Published by
MarketsandMarkets
Product code
1031216
Published
October 1, 2021
Content info
224 Pages
Price
USD 4950
Sample available
Adalimumab, Infliximab and Etanercept Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028953
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Biosimilar Monoclonal Antibodies Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028931
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Biosimilar Interleukins Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028898
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Filgrastim Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028893
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Trastuzumab Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028886
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Generic Pharmaceuticals Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028825
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Oncology Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028798
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Biosimilars Global Market Report 2021: COVID-19 Growth And Change To 2030
Published by
The Business Research Company
Product code
1028797
Published
Pre-Order
Content info
175 Pages
Price
USD 5000
Sample available
Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive / Terminated / Withdrawn Biosimilars, Industry / Non-Industry Partnerships
Published by
Roots Analysis
Product code
1031040
Published
August 31, 2021
Content info
70 Pages
Price
USD 949
Sample available
Avastin (Bevacizumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars, Inactive / Terminated / Withdrawn Biosimilars, Industry / Non-Industry Partnerships
Published by
Roots Analysis
Product code
1031034
Published
August 31, 2021
Content info
91 Pages
Price
USD 949
Sample available
Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Insight 2026
Published by
KuicK Research
Product code
1023442
Published
August 18, 2021
Content info
600 Pages
Price
USD 3300
Sample available
Generic Drugs Companies in China
Published by
Asia Market Information & Development Co.
Product code
358304
Published
August 9, 2021
Content info
56 Pages
Price
USD 1800
Sample available
Generic Drugs Industry Forecasts - China Focus
Published by
Asia Market Information & Development Co.
Product code
358301
Published
August 9, 2021
Content info
108 Pages
Price
USD 1800
Sample available
Generic Drugs Markets in China
Published by
Asia Market Information & Development Co.
Product code
358264
Published
August 9, 2021
Content info
220 Pages
Price
USD 4000
Sample available
*
Published by
IMARC Services Private Limited
Product code
1021988
Published
August 2, 2021
Content info
110 Pages
Price
USD 1999
Sample available
*
Published by
IMARC Services Private Limited
Product code
1021987
Published
August 2, 2021
Content info
140 Pages
Price
USD 2499
Sample available
Remicade Biosimilar Market with COVID-19 Impact Analysis, By Technology, By Application, and By Region - Size, Share, & Forecast from 2021-2027
Published by
AnalystView Market Insights
Product code
1023693
Published
August 1, 2021
Content info
321 Pages
Price
USD 3250
Sample available
US Biosimilar Insulin Market Opportunity & Clinical Trials Insight 2026
Published by
KuicK Research
Product code
1023610
Published
August 1, 2021
Content info
50 Pages
Price
USD 2400
Sample available
*
Published by
MarketLine
Product code
1023580
Published
July 21, 2021
Content info
277 Pages
Price
USD 1495
Sample available
*
Published by
MarketLine
Product code
1023579
Published
July 21, 2021
Content info
134 Pages
Price
USD 995
Sample available
*
Published by
MarketLine
Product code
1023578
Published
July 21, 2021
Content info
120 Pages
Price
USD 995
Sample available
*
Published by
MarketLine
Product code
1023577
Published
July 21, 2021
Content info
177 Pages
Price
USD 1495
Sample available
*
Published by
MarketLine
Product code
1023576
Published
July 21, 2021
Content info
488 Pages
Price
USD 2995
Sample available
Global Biosimilar Insulin Sales Market Report 2021
Published by
QYResearch
Product code
1018994
Published
July 19, 2021
Content info
124 Pages
Price
USD 4000
Sample available